跳至主要内容
临床试验/IRCT2017080619470N61
IRCT2017080619470N61已完成4 期

Comparison of Preconditioning Effect of High Dose and Low Dose Atorvastatin Treatment in Patients Underwent CABG

Vice Chancellor for Research, Shiraz University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • patients who had been taking (atorvastatin 20 mg daily) at least one year prior to the cardiac surgery.
  • Exclusion criteria:
  • unstable angina; evidences of recent MI (within 6 months) ; history of cardiac surgery; congenital heart disease; history of cardiac arrhythmia (arterial fibrillation) before surgery; receiving anti- arrhythmic drugs (except Beta blockers) ; having pacemaker; left ventricle ejection fraction less than 30%, uncontrolled hypertension; arterial or ventricular arrhythmia; pregnancy; patient who are undergoing diabetes treatment; increased level of liver enzymes; renal failure with creatinine more than 2 mg/dl; active inflammation or immune deficiency; positive history of muscle disease or reaction to the stations.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Shiraz University of Medical Sciences

相似试验